TECHNOLOGY

ANTIBODY DEVELOPMENT

AIMEDBIO is developing therapeutic antibodies and antibody-drug conjugate (ADC) for the treatment of brain diseases and tumor.
Antibody Generation
Antibody Optimization
Antibody Production

IMMUNO-ONCOLOGY RESEARCH

AIMEDBIO focuses on unveiling the mechanism behind how cancer cells evade the immune system by studying macrophage, microglia and lymphocytes. We are also interested in modulating neuro-inflammation as therapeutic approaches targeting brain diseases

HTS/HCS SYSTEMS

AIMEDBIO is currently using High Throughput/ Content Screening (HTS/HCS) Platform to robustly and efficiently identify novel therapeutics

PDC/PDX

AIMEDBIO uses Patient-derived Cell/Xenograft (PDC/PDX) to increase the success of translational research
Genome, transcriptome, epigenome, proteome and drug screening data are analyzed and applied to big data-driven drug discovery and development